Posted inInfections, New Drugs, Regulatory Vivjoa: First Drug for Chronic Vaginal Yeast Infection May 1, 2022September 8, 2022 Oteseconazole by Mycovia Pharmaceuticals will prevent the risk of recurrent episodes of vulvovaginal candidiasis.
